Blueberries Medical Lists on Frankfurt Stock Exchange Under Symbol 1OA
March 04, 2019 07:30 ET
|
Blueberries Medical Corp.
TORONTO, March 04, 2019 (GLOBE NEWSWIRE) -- Blueberries Medical Corp. (CSE: BBM) (OTC: BBRRF) (FRA: 1OA) (the “Company” or "Blueberries"), a leading Colombia-based licensed producer of medicinal...
New Era Completes Private Placement
February 14, 2019 08:00 ET
|
New Era Minerals Inc.
VANCOUVER, British Columbia, Feb. 14, 2019 (GLOBE NEWSWIRE) -- New Era Minerals Inc. (TSXV: NEM; “New Era” or the “Company”) announced today that it has completed a private placement with an...
Vogogo Inc. Announces Thirty for One Share Consolidation
February 05, 2019 18:05 ET
|
Vogogo Inc.
TORONTO, Feb. 05, 2019 (GLOBE NEWSWIRE) -- Vogogo Inc. (“Vogogo” or the “Company”) (CSE:VGO) announced today that its Board of Directors has authorized the implementation of a share consolidation of...
Stella-Jones annonce une offre publique de rachat dans le cours normal des activités
December 18, 2018 07:00 ET
|
Stella-Jones Inc
MONTRÉAL, 18 déc. 2018 (GLOBE NEWSWIRE) -- Stella-Jones Inc. (TSX : SJ) (« Stella-Jones » ou la « Société ») a annoncé aujourd’hui que la Bourse de Toronto (la « TSX ») avait accepté son...
Stella-Jones Announces Normal Course Issuer Bid
December 18, 2018 07:00 ET
|
Stella-Jones Inc.
MONTREAL, Dec. 18, 2018 (GLOBE NEWSWIRE) -- Stella-Jones Inc. (TSX: SJ) (“Stella-Jones” or the “Company”) announced today that the Toronto Stock Exchange (“TSX”) has accepted its Notice of Intention...
VBI Vaccines Announces Pricing of $37.5 Million Public Offering
December 13, 2018 09:05 ET
|
VBI Vaccines, Inc.
CAMBRIDGE, Mass., Dec. 13, 2018 (GLOBE NEWSWIRE) -- VBI Vaccines Inc. (Nasdaq: VBIV) (VBI), a commercial-stage biopharmaceutical company developing next-generation infectious disease and...
VBI Vaccines Announces Proposed Public Offering of Common Shares
December 12, 2018 16:01 ET
|
VBI Vaccines, Inc.
CAMBRIDGE, Mass., Dec. 12, 2018 (GLOBE NEWSWIRE) -- VBI Vaccines Inc. (Nasdaq: VBIV) (VBI), a commercial-stage biopharmaceutical company developing next-generation infectious disease and...
Emerald Health Therapeutics Closes $10.8 Million Prospectus Sale
December 07, 2018 18:11 ET
|
Emerald Health Therapeutics Inc.
VICTORIA, British Columbia, Dec. 07, 2018 (GLOBE NEWSWIRE) -- Emerald Health Therapeutics, Inc. (TSXV:EMH; OTCQX:EMHTF) ("Emerald" or the “Company”) closed today its prospectus sale (the “Offering”)...
Capital Power declares dividends for its Common and Preference shares
October 26, 2018 16:30 ET
|
Capital Power Corporation
EDMONTON, Alberta, Oct. 26, 2018 (GLOBE NEWSWIRE) -- The Board of Directors for Capital Power Corporation (TSX: CPX) (Capital Power) declared a dividend of $0.4475 per share on the outstanding...
Breathtec Announces Signing of Definitive Agreement to Acquire Nash Pharmaceuticals
October 09, 2018 07:00 ET
|
Breathtec Biomedical Inc.
VANCOUVER, British Columbia, Oct. 09, 2018 (GLOBE NEWSWIRE) -- Breathtec Biomedical Inc. (CSE: BTH) (CNSX: BTH) (FRANKFURT: BTI) (OTCQB: BTHCF) (the “Company” or “Breathtec”) is pleased to announce...